ICD-10 Code C11.1
Malignant neoplasm of posterior wall of nasopharynx
C11.1 is the International Classification of Diseases, Tenth Revision (ICD-10) code used to classify a malignant neoplasm of the posterior wall of the nasopharynx, a specific type of head and neck cancer located in the upper throat behind the nasal cavity. Clinically, this diagnosis primarily encompasses nasopharyngeal carcinomas, including non-keratinizing squamous cell carcinoma, keratinizing squamous cell carcinoma, and lymphoepithelioma, which frequently arise in or extend across the adenoid tissue and mucosal lining of the posterior nasopharyngeal wall. Etiological factors commonly associated with this malignancy include chronic Epstein-Barr virus infection, genetic predisposition, and dietary exposures such as heavy consumption of nitrosamine-rich salt-cured foods. Patients presenting with tumors in this area often display symptoms such as painless cervical lymphadenopathy from regional lymph node metastasis, unilateral nasal obstruction, recurrent epistaxis, middle ear effusion, and hearing impairment due to Eustachian tube blockage. Related conditions and secondary diagnoses associated with this code include malignant tumors of the pharyngeal tonsil region, secondary malignant neoplasms of the cervical lymph nodes, and Eustachian tube dysfunction secondary to head and neck neoplasm.
- Malignant neoplasm of adenoid
- Malignant neoplasm of pharyngeal tonsil
C11.1 is a valid billable ICD-10 diagnosis code for Malignant neoplasm of posterior wall of nasopharynx. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.
Check for any exclusions, inclusions or special notations associated with C11.1
C11.1 also applies to the following:
- Malignant neoplasm of adenoid
- Malignant neoplasm of pharyngeal tonsil
See also, ICD-10 Table of Neoplasms.
- MDC 03 Diseases & Disorders of the Ear, Nose, Mouth & Throat
Ear, Nose, Mouth and Throat Malignancy
ICD-10 code C11.1 is based on the following Tabular structure:
Chapter 2: Neoplasms- Section C00-C14: Malignant neoplasms of lip, oral cavity and pharynx
- Category C11: Malignant neoplasm of nasopharynx
Should you use C11.1 or C111 (with or without decimal point) when submitting claims?
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you
but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.
This note further define, or give examples of, the content of the code or category.
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.
A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.